Matthew T. Wiley

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Rehovot
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/Mark Sullivan, Attorney-in-Fact for Matthew T. Wiley
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Matthew T. Wiley

Form 4 holding Chief Commercial Officer

VYNE Therapeutics Inc.

Security class
Common Stock
Shares / value
109,246
Estimated value
$249,081
Report date
30 Jun 2021
Price
$2.28
Ownership
Direct
Form 4 holding Chief Commercial Officer

BioXcel Therapeutics, Inc.

Security class
Common Stock
Shares / value
19,011
Estimated value
$10,456
Report date
03 Oct 2024
Price
$0.5500
Ownership
Direct
Form 4 holding Chief Commercial Officer

BioXcel Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
7,500
Estimated value
$9,600
Report date
15 Sep 2024
Price
$1.28
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Commercial Officer

Mind Medicine (MindMed) Inc.

Security class
Stock Option (Right to Buy)
Shares / value
350,000
Estimated value
Report date
17 Mar 2025
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chief Commercial Officer

BioXcel Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
1,875
Estimated value
Report date
22 Jul 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Matthew T. Wiley

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .